title: Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients.
authors.affiliation: Nephrology Department, Lapeyronie University Hospital, Montpellier, France.
authors.forename: C G
authors.initials: CG
authors.lastname: Vela
authors.forename: J P
authors.initials: JP
authors.lastname: Cristol
authors.forename: B
authors.initials: B
authors.lastname: Descomps
authors.forename: G
authors.initials: G
authors.lastname: Mourad
mesh_terms: D000328:Adult; D001055:Apolipoproteins B / Q000097:blood; D002784:Cholesterol / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology*; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000097:blood / Q000139:chemically induced; D011446:Prospective Studies; D016559:Tacrolimus / Q000009:adverse effects*; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
chemical_list: D001055:Apolipoproteins B; D008078:Cholesterol, LDL; D007166:Immunosuppressive Agents; D008055:Lipids; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D016559:Tacrolimus